Cyteir Therapeutics Inc (CYT) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cyteir Therapeutics Inc   (NASDAQ: CYT)


Cyteir Therapeutics Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Cyteir Therapeutics Inc 's ROA in the third quarter of 2023?
Cyteir Therapeutics Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -23.77%.

However, within the Healthcare sector 412 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 3965, from total ROA ranking in the second quarter of 2023 at 4125.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -18.98 % -22.93 % -25.26 % -21.64 % -21.55 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -33 -41 -44 -46 -49
Return On Assets (TTM) -23.77 % -27.63 % -28.24 % -27.23 % -27.3 %
CYT's Total Ranking # 3965 # 4125 # 4255 # 4867 # 4376
Total Assets (TTM) in million 131 134 139 155 162
Seq. Total Assets Change -2.51 % -3.3 % -10.06 % -4.44 % -7.27 %
Seq. Net Income Change - - - - -

CYT's 5 Years Annual ROA >> Back to CYT Management Effectiveness >> Compare CYT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 162
Sector # 413
Overall # 3898

Return On Assets Statistics
High Average Low
8.13 %
-4.64 %
-28.3 %
(Sep 30 2014)   (Mar 31 2023)





Financial Statements
Cyteir Therapeutics Inc 's Assets $ 131 million CYT's Balance sheet
Cyteir Therapeutics Inc 's Income $ -4 million Quarterly CYT's Income Statement
CYT's Income by Division See CYT's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2014)
FY 2014		 (Dec 31 2013)
FY 2013		 (Dec 31 2012)
FY 2012
Y / Y Total Assets Change -21.58 % -92.94 % 3.23 % -31.66 % 10.9 %
Total Assets in million 153 195 2,767 2,681 3,922
Y / Y Net Income Change - - -11.56 % -8.52 % -9.86 %
Net Income in million -46 -42 154 174 190
Annual Return On Assets -30.06 % -21.56 % 5.56 % 6.49 % 4.85 %

CYT's 5 Years Annual ROA >> Back to CYT Management Effectiveness >> Compare CYT ROA to its Competitors



More Return On Assets Ratios
CYT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYT's Competitors
Subscribers only: Roa for Cyteir Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for CYT's Customers

You may also want to know
CYT's Roi CYT's Inventory Turnover Ratio CYT's Growth Rates CYT's Dividend Comparisons
CYT's Profitability Ratios CYT's Asset Turnover Ratio CYT's Dividend Growth
CYT's Roe CYT's Valuation Ratios CYT's Financial Strength Ratios CYT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-26T07:39:43+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.